Optimal Time on HAART for Prevention of Mother-to-Child Transmission of HIV
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 58 (2) , 224-228
Abstract
Objectives: To determine the impact of time between initiating highly active antiretroviral therapy (HAART) and delivery—duration of antenatal HAART—on perinatal HIV infection. Design: We conducted a retrospective cohort analysis of pregnant HIV-infected women in Lusaka, Zambia. Women in our cohort were receiving HAART and had an infant HIV polymerase chain reaction test between 3 and 12 weeks of life. Methods: We examined factors associated with infant HIV infection and performed a locally weighted regression analysis to examine the effect of duration of antenatal HAART on perinatal HIV infection. Results: From January 2007 to March 2010, 1813 HIV-infected pregnant women met inclusion criteria. Mean gestational age at first antenatal visit was 21 weeks (SD ± 6), median CD4+ cell count was 231 cells per microliter (interquartile range: 164-329), and median duration of antenatal HAART was 13 weeks (interquartile range 8-19). Fifty-nine (3.3%) infants were HIV infected. Duration of antenatal HAART was the most important predictor of perinatal HIV transmission. Compared with women initiating HAART at least 13 weeks before delivery, women on HAART for ≤4 weeks had a 5.5-fold increased odds of HIV transmission (95% confidence interval: 2.6 to 11.7). Locally weighted regression analysis suggested limited additional prophylactic benefit beyond 13 weeks on antenatal HAART. Conclusions: Low rates of mother-to-child HIV transmission can be achieved within programatic settings in Africa. Maximal effectiveness of prevention of mother-to-child transmission programs is achieved by initiating HAART at least 13 weeks before delivery.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of the PIMA Point-of-Care CD4 Analyzer in VCT Clinics in ZimbabweJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Preventing Mother-to-Child Transmission of HIV in Resource-Limited Settings: The Elizabeth Glaser Pediatric AIDS Foundation ExperienceAmerican Journal of Public Health, 2009
- Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal CohortAIDS, 2008
- Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countriesAmerican Journal of Obstetrics and Gynecology, 2007
- Late Postnatal Transmission of HIV‐1 and Associated FactorsThe Journal of Infectious Diseases, 2007
- Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIVAIDS, 2007
- Time to Undetectable Viral Load after Highly Active Antiretroviral Therapy Initiation among HIV-Infected Pregnant WomenClinical Infectious Diseases, 2007
- Expanded Services for the Prevention of Mother-to-Child HIV TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in MalawiAIDS, 2006
- Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in ZambiaJAMA, 2006